Differentiate your CNS offering with precision digital endpoints
Pharma sponsors are moving beyond subjective clinical scales. NeuroQuantix gives your CNS team objective, regulatory-grade digital motor endpoints that reduce sample sizes, improve data quality, and strengthen your competitive positioning.
Why CROs choose NeuroQuantix
Strengthen your CNS clinical trial capabilities with technology that sponsors increasingly expect from their CRO partners.
Win More Sponsor Business
Pharma sponsors increasingly demand objective, digital endpoints for CNS trials. Offer NeuroQuantix as part of your CNS service portfolio to differentiate from competitors relying solely on traditional scales.
Reduce Trial Costs for Clients
Published data shows digital spiral metrics require up to 3x fewer subjects per arm to achieve equivalent statistical power. Smaller enrollment means faster timelines and lower costs.
Regulatory-Grade Data
21 CFR Part 11 compliant with CDISC data exports, complete audit trails, and GxP-compatible deployment. Built for the regulatory scrutiny your sponsor clients face.
Objective Measurement
Eliminate inter-rater variability that undermines multi-site CNS trials. 397 automated kinematic metrics replace subjective observer ratings with continuous, quantitative data.
Global Deployment Ready
Designed for regulatory submissions to FDA, EMA, PMDA, TGA, and Health Canada. Cloud-hosted with site-level access control and real-time data monitoring.
Minimal Site Burden
iPad Pro or Wacom digitizer deployment. Under 30 minutes to site operational readiness. No specialized technician required — standard clinical site staff can administer.
The competitive advantage
vs. traditional clinical scales at equivalent power
From a single 2-minute drawing task
Published reliability for tremor metrics
FDA, EMA, PMDA, TGA, Health Canada
Fits your existing infrastructure
NeuroQuantix integrates with the EDC platforms, eCOA systems, and data management workflows your team already uses. CDISC-compliant exports flow directly into your existing regulatory submission pipeline.
Partnership Model
Strengthen your CNS capabilities
Schedule a partnership discussion to explore how NeuroQuantix integrates into your CNS clinical trial service offering.
Start the Conversation